AAM, Biosimilars Forum call on CMS to support lower-cost biosimilars, increase access for patientsAAM and The Biosimilars Forum state that the uncertainty created by the IRA harms generic and biosimilar competition. Ahead of the curveDSN caught up with Jessica Collette, senior director of sales & marketing at Amici, to learn more about the company's latest developments and innovations in the generics space. Sponsored Alembic intros generic Rheumatrex Methotrexate Tablets are indicated for the treatment of adults and pediatric patients with acute lymphoblastic leukemia as part of a combination chemotherapy maintenance regimen. Celltrion USA adds Humira biosimilar to Costco Member Prescription Program Adalimumab-aaty is approved for the treatment of a wide range of conditions. Novartis loses initial bid to block MSN's generic Entresto MSN's version of the heart failure drug Entresto would be the first U.S. generic of the drug. Alembic receives FDA OK for generic Arranon Nelarabine is indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and lymphoma in certain patients. Sandoz receives FDA approval for Eyelea biosimilar Enzeevu is approved to treat neovascular age-related macular degeneration. FDA gives Lupin nod for generic Pred Forte, tentative OK for generic Descovy The company received approval for generic Pred Forte and generic Descovy. Mallinckrodt to sell Therakos business to CVC for $925M Therakos is a fully integrated extracorporeal photopheresis delivery system for autologous immunomodulatory therapy. ANI Pharmaceuticals announces proposed convertible senior notes offering ANI also expects to grant the initial purchasers of the notes an option to purchase. First Previous 13 14 15 16 17 Next Last
